Satisfaction and continuation with LNG-IUS 12: findings from the real-world kyleena^® satisfaction study

Abstract

Results from KYSS provide the first real-world evidence assessing LNG-IUS 12, and demonstrate high satisfaction and continuation rates irrespective of age or parity. <b>Clinical trial registration:</b> NCT03182140.